InVitro International (IVRO)
USD 0.1
(15.93%)
USD 0.1
(15.93%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.53 Million USD | 1.59% |
| 2022 | 1.51 Million USD | -7.47% |
| 2021 | 1.63 Million USD | 6.03% |
| 2020 | 1.53 Million USD | 11.54% |
| 2019 | 1.37 Million USD | 14.24% |
| 2018 | 1.2 Million USD | 4.07% |
| 2017 | 1.16 Million USD | 4.49% |
| 2016 | 1.11 Million USD | 14.36% |
| 2015 | 971.3 Thousand USD | 0.0% |
| 1996 | 2.4 Million USD | -25.0% |
| 1995 | 3.2 Million USD | -50.77% |
| 1994 | 6.5 Million USD | 20.37% |
| 1993 | 5.4 Million USD | 125.0% |
| 1992 | 2.4 Million USD | -61.9% |
| 1991 | 6.3 Million USD | 173.91% |
| 1990 | 2.3 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.54 Million USD | 0.72% |
| 2024 Q3 | 1.59 Million USD | 0.89% |
| 2024 Q2 | 1.58 Million USD | 2.34% |
| 2023 Q2 | 1.45 Million USD | -0.99% |
| 2023 FY | 1.53 Million USD | 1.59% |
| 2023 Q1 | 1.47 Million USD | -2.43% |
| 2023 Q4 | 1.53 Million USD | 5.14% |
| 2023 Q3 | 1.45 Million USD | 0.01% |
| 2022 Q2 | 1.53 Million USD | -2.89% |
| 2022 FY | 1.51 Million USD | -7.47% |
| 2022 Q4 | 1.51 Million USD | -0.15% |
| 2022 Q1 | 1.58 Million USD | -3.15% |
| 2022 Q3 | 1.51 Million USD | -1.46% |
| 2021 Q2 | 1.44 Million USD | 0.0% |
| 2021 FY | 1.63 Million USD | 6.03% |
| 2021 Q4 | 1.63 Million USD | -0.82% |
| 2021 Q3 | 1.64 Million USD | 13.57% |
| 2020 FY | 1.53 Million USD | 11.54% |
| 2019 FY | 1.37 Million USD | 14.24% |
| 2018 FY | 1.2 Million USD | 4.07% |
| 2017 FY | 1.16 Million USD | 4.49% |
| 2016 FY | 1.11 Million USD | 14.36% |
| 2015 FY | 971.3 Thousand USD | 0.0% |
| 1997 Q3 | 1.15 Million USD | -18.6% |
| 1997 Q2 | 1.41 Million USD | 0.0% |
| 1996 Q4 | 2.4 Million USD | -11.11% |
| 1996 FY | 2.4 Million USD | -25.0% |
| 1996 Q3 | 2.7 Million USD | 28.57% |
| 1996 Q1 | 2.6 Million USD | -18.75% |
| 1996 Q2 | 2.1 Million USD | -19.23% |
| 1995 Q4 | 3.2 Million USD | 0.0% |
| 1995 FY | 3.2 Million USD | -50.77% |
| 1994 Q3 | 7.6 Million USD | -12.64% |
| 1994 FY | 6.5 Million USD | 20.37% |
| 1994 Q4 | 6.5 Million USD | -14.47% |
| 1994 Q2 | 8.7 Million USD | -12.12% |
| 1994 Q1 | 9.9 Million USD | 83.33% |
| 1993 Q4 | 5.4 Million USD | -22.86% |
| 1993 Q2 | 2.6 Million USD | -25.71% |
| 1993 Q1 | 3.5 Million USD | 45.83% |
| 1993 Q3 | 7 Million USD | 169.23% |
| 1993 FY | 5.4 Million USD | 125.0% |
| 1992 Q2 | 4.7 Million USD | 0.0% |
| 1992 FY | 2.4 Million USD | -61.9% |
| 1992 Q3 | 3.1 Million USD | -34.04% |
| 1992 Q4 | 2.4 Million USD | -22.58% |
| 1991 Q3 | 7.7 Million USD | 234.78% |
| 1991 Q2 | 2.3 Million USD | 0.0% |
| 1991 Q4 | 6.7 Million USD | -12.99% |
| 1991 FY | 6.3 Million USD | 173.91% |
| 1990 FY | 2.3 Million USD | 0.0% |
| 1990 Q2 | 900 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Bio Medica Corporation | 1.26 Million USD | -20.883% |
| Arrayit Corporation | 1 Million USD | -53.341% |
| Atlantic International Corp. | 4.43 Million USD | 65.422% |
| Biocept, Inc. | 30.87 Million USD | 95.031% |
| Bioqual, Inc. | 56.58 Million USD | 97.289% |
| CardioGenics Holdings Inc | 231.93 Thousand USD | -561.404% |
| DermTech, Inc. | 121.93 Million USD | 98.742% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 4.18 Billion USD | 99.963% |
| HTG Molecular Diagnostics, Inc. | 17.77 Million USD | 91.371% |
| iMD Companies, Inc. | 190.13 Thousand USD | -706.79% |
| IDenta Corp. | 1.52 Million USD | -0.309% |
| Interpace Biosciences, Inc. | 13.02 Million USD | 88.219% |
| Integrative Health Technologies, Inc. | 8.25 Million USD | 81.41% |
| Lumos Diagnostics Holdings Limited | 26.83 Million USD | 94.284% |
| Many Bright Ideas Technologies Inc. | 2312.00 USD | -66249.784% |
| Medical Imaging Corp. | 4.19 Million USD | 63.403% |
| NovelStem International Corp. | 2.25 Million USD | 31.959% |
| Optigenex Inc. | 1.88 Million USD | 18.762% |
| PharmChem, Inc. | 2.76 Million USD | 44.532% |
| Proteome Sciences plc | 14.58 Million USD | 89.483% |
| Response Genetics, Inc | 48.88 Million USD | 96.862% |
| Rennova Health, Inc. | 20.57 Million USD | 92.544% |
| RushNet, Inc. | 6.04 Million USD | 74.634% |
| ScreenPro Security Inc. | 1.26 Million USD | -21.615% |
| Stella Diagnostics Inc. | 472.42 Thousand USD | -224.71% |
| StageZero Life Sciences Ltd. | 700.65 Thousand USD | -118.94% |
| Todos Medical Ltd. | 15.26 Million USD | 89.952% |